Carrier-Tumor Cell Membrane Interactions for Optimized Delivery of a Promising Drug, 4(<i>RS</i>)-4-F<sub>4t</sub>-Neuroprostane
Nanomedicines engineered to deliver molecules with therapeutic potentials, overcoming drawbacks such as poor solubility, toxicity or a short half-life, are targeted towards their cellular destination either passively or through various elements of cell membranes. The differences in the physicochemic...
Saved in:
Main Authors: | Ariana Abawi (Author), Céline Thomann (Author), Giovanna Lollo (Author), Thierry Granjon (Author), Emma Petiot (Author), Anna Bérot (Author), Camille Oger (Author), Valérie Bultel-Poncé (Author), Alexandre Guy (Author), Jean-Marie Galano (Author), Thierry Durand (Author), Agnès Girard-Egrot (Author), Ofelia Maniti (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, Synthesis, and Biological Evaluation of 4,4'-Difluorobenzhydrol Carbamates as Selective M<sub>1</sub> Antagonists
by: Jonas Kilian, et al.
Published: (2022) -
Mechanistic Study of Antimicrobial Effectiveness of Cyclic Amphipathic Peptide [R<sub>4</sub>W<sub>4</sub>] against Methicillin-Resistant <i>Staphylococcus aureus</i> Clinical Isolates
by: Ajayi David Akinwale, et al.
Published: (2024) -
Competition between H<sub>4</sub>PteGlu and H<sub>2</sub>PtePAS Confers <i>para</i>-Aminosalicylic Acid Resistance in <i>Mycobacterium tuberculosis</i>
by: Ji-Fang Yu, et al.
Published: (2023) -
Development of Biocompatible Ga<sub>2</sub>(HPO<sub>4</sub>)<sub>3</sub> Nanoparticles as an Antimicrobial Agent with Improved Ga Resistance Development Profile against <i>Pseudomonas aeruginosa</i>
by: Huda Alamri, et al.
Published: (2023) -
Combination of Amphiphilic Cyclic Peptide [R<sub>4</sub>W<sub>4</sub>] and Levofloxacin against Multidrug-Resistant Bacteria
by: Muhammad Imran Sajid, et al.
Published: (2022)